Most dietary approaches give you a meal plan and leave the rest to willpower. CNFCD — developed by Weikang and built on 160,000 real client data points — is a metabolic coaching system that adapts to individual biology rather than applying a standard template.

Depression and obesity co-occur at rates far above chance — and the gut microbiome is a key shared mechanism. Dysbiosis drives both systemic inflammation and disrupted neurotransmitter production, creating bidirectional links between gut health, mood, and body weight.

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women — and insulin resistance is its primary driver, not ovarian dysfunction. This article explains the metabolic mechanism behind PCOS and why addressing insulin sensitivity is central to treatment.

Taiwan has the world's highest dialysis prevalence rate — and metabolic syndrome is the primary driver. Diabetes and hypertension, both driven by insulin resistance, account for over 60% of new dialysis cases. This article explains how kidney disease develops and the dietary approach to prevention.

Sarcopenia — progressive loss of muscle mass and strength — begins in your 30s and accelerates after 50. It reduces metabolic rate, worsens insulin sensitivity, and increases all-cause mortality. This article explains why preserving muscle is essential for metabolic health.

The 2026 US Dietary Guidelines reversed 30 years of policy by clearing full-fat dairy and removing the egg cholesterol limit. This article explains what the science actually showed, why the previous guidelines were flawed, and what this means for your diet.

Obstructive sleep apnea and obesity drive each other in a vicious cycle. Excess fat around the airway collapses breathing during sleep; fragmented sleep worsens hormonal fat storage; worse metabolic function makes weight loss harder. This article explains how to break the cycle.

Gastroesophageal reflux disease (GERD) is strongly associated with abdominal obesity — not just acid production. Visceral fat increases intra-abdominal pressure, forces the lower esophageal sphincter open, and drives reflux. This article explains the mechanism and the dietary approach.

GLP-1 receptor agonists like semaglutide produce significant weight loss but come with important considerations: muscle loss, rebound weight gain after stopping, and the question of whether they address the metabolic root cause or defer it.